Find Academic Supervisors

Ole Nørregaard JensenView profile

Professor

• Mass Spectrometry
• Proteomics
• Posttranslational Modification
• +9 more

Ole Nørregaard Jensen is a Professor in Biomedical Mass Spectrometry and Systems Biology at the Department of Biochemistry and Molecular Biology, University of Southern Denmark . His research integrates advanced mass spectrometry, proteomics, and bioinformatics to study chromatin biology, post-translational modifications, and cellular signaling networks. He is actively involved in major research initiatives funded by Novo Nordisk Foundation and Lundbeck Foundation. His research interests include Mass Spectrometry, Proteomics, Posttranslational Modification, Histone Biology, Chromatin Biology, Bioinformatics, Systems Biology, Lipidomics, and Protein Chemistry . He employs cutting-edge techniques such as tandem mass spectrometry and ion mobility spectrometry to analyze protein isomers and dynamic modifications. His work has significant implications for understanding gene regulation, DNA replication, and disease mechanisms. His recent publications demonstrate a strong trend in chromatin dynamics, epigenetics, and integrated omics approaches , combining proteomics with transcriptomics and lipidomics to unravel complex biological systems. His research spans from fundamental molecular mechanisms to translational applications in biomedicine and food science. He has been recognized with several prestigious awards: MCP Lectureship Award Juan Pablo Albar Proteomics Pioneer Award 2019 EliteForsk 2009 prize Knight Order of Dannebrog (Ridder af Dannebrogordenen) Jensen is deeply involved in academic service, including peer review for journals like Nature Communications and Molecular and Cellular Proteomics , organizing conferences, and supervising students. He teaches courses such as Biomedical Mass Spectrometry - Principles and Applications and coordinates the Computational Biomedicine international Master’s program. He leads multiple active research projects, including PLATO and INTEGRA, focusing on health data, imaging, and protein networks. He is a key member of a vibrant research environment in biomedical mass spectrometry at SDU, contributing to both national and international scientific collaborations. His lab is at the forefront of developing and applying novel mass spectrometry methodologies for systems biology.

Tracy RosebrockView profile

Assistant Professor

• Microbiology
• Plant Pathology
• Immunology
• +4 more

Tracy Rosebrock serves as Assistant Professor of Biology at Stonehill College, where she was honored with the 2022 Louise F. Hegarty Award for Excellence in Teaching. Her teaching excellence is characterized by compassionate mentorship, challenging yet supportive pedagogy, and an open-door policy that has made her a trusted advisor. Students consistently praise her ability to simplify complex biological concepts while inspiring academic excellence and fostering a positive learning environment. Professor Rosebrock's research spans two critical areas of pathogen-host interactions: tuberculosis immunology and plant-microbe dynamics. Her tuberculosis work investigates macrophage signaling pathways, antibiotic resistance mechanisms in mycobacteria, and antibody-mediated immune responses. In plant pathology, she examines ubiquitin-mediated immune regulation, bacterial effector proteins that suppress host defenses, and viral disease emergence. This dual focus demonstrates her interdisciplinary approach to understanding fundamental biological defense mechanisms across kingdoms. Her publication record from 2002-2019 reveals consistent contributions to understanding host-pathogen conflicts, with recent work emphasizing immune signaling in tuberculosis control and ubiquitin pathways in plant immunity. These research trajectories highlight her commitment to addressing both human health challenges and agricultural security through molecular investigation. Scientific Recognition: Louise F. Hegarty Award for Excellence in Teaching (2022) - Stonehill College's highest teaching honor, awarded for transformative student impact and pedagogical excellence As an academic advisor, Professor Rosebrock maintains an exceptionally supportive relationship with students, described as "a listening ear, a shoulder to cry on, and a mentor." Her teaching philosophy integrates Aristotle's principle that "educating the mind without educating the heart is no education at all," creating classrooms where students feel empowered to reach their highest potential. While specific research grants aren't detailed in available materials, her sustained publication output indicates active research programs in microbiological and plant pathological systems.

Veit Stefan SchwämmleView profile

Associate Professor

• Proteomics
• Bioinformatics
• Mass Spectrom
• +3 more

Veit Stefan Schwämmle is an Associate Professor at the Department of Biochemistry and Molecular Biology, University of Southern Denmark. His work focuses on biomedical mass spectrometry and systems biology, with expertise in proteomics, bioinformatics, and computational modeling of multivalent histone modifications in gene regulation. Research Interests: His research combines statistical data analysis, Monte Carlo simulations, and advanced mass spectrometry techniques to study proteomics, posttranslational modifications, and their applications in biomedical contexts. Key areas include liquid chromatography-mass spectrometry, bottom-up proteomics, and privacy-preserving data analysis methods. Projects: He participates in EU Horizon Europe initiatives like ELIXIR-STEERS and ELIXIR-STREERS, focusing on research infrastructure and bioinformatics. His involvement in projects such as PROTEIN and Elixir Hub highlights his contributions to multicenter proteomics and data standardization. Activities: A seasoned lecturer, he has delivered presentations on computational proteomics, statistics, and bioinformatics in both academic and industry settings since 2012, emphasizing large datasets and analytical rigor.

Axel ImhofView profile

Professor

• Posttranslational protein modifications
• Protein methylation
• Protein acetylation
• +7 more

Prof. Dr. Axel Imhof is a faculty member at the Biomedical Center (BMC) of Ludwig-Maximilians-Universität München. His research focuses on the dynamics and functional implications of posttranslational protein modifications, particularly lysine methylation and acetylation in histones and other regulatory proteins. Key projects include mapping the human lysine methylome, analyzing methyltransferase substrate specificity, and pioneering MALDI imaging techniques for spatial analysis of modified proteins and nucleic acids in tissues. Email: aimhof@med.uni-muenchen.de . Associated with the Collaborative Research Centre 1309 (SFB 1309) Area B project B03, which investigates protein modification mechanisms through biochemical strategies and advanced imaging technologies.

• Proteomics
• Mass Spectrometry
• Posttranslational Modifications
• +7 more

Al Burlingame is a Professor in the Department of Pharmaceutical Chemistry at the University of California, San Francisco (UCSF). He is the Director of the Mass Spectrometry Facility and affiliated with the UCSF Helen Diller Family Comprehensive Cancer Center and Quantitative Biosciences Institute (QBI). His research focuses on advancing mass spectrometry methodologies for proteomics, epigenetic studies, and systems biology, particularly in posttranslational modifications and protein complex analysis. He holds a PhD from MIT (1962) and a BS from the University of Rhode Island (1959). His research expertise includes bioanalytical chemistry, mass spectrometry, and structural biology. Key contributions include pioneering work on protein cross-linking strategies, O-GlcNAcylation dynamics, and software tools like Protein Prospector for proteomic data analysis. He has held leadership roles in academic and professional organizations, including editorial roles in journals like Molecular & Cellular Proteomics. Burlingame's honors include the Albert Nelson Marquis Lifetime Achievement Award (2018), the MCP Lectureship (2013), and the Achievement Award from the International Forum of Proteomics (2012). His work has been featured in high-impact journals across proteomics, cancer biology, and neuroscience. He has advised numerous researchers and contributed to grants focusing on mass spectrometry applications in health and disease. His labs focus on advancing proteomic technologies and understanding protein dynamics in cellular systems, with collaborations spanning neurobiology, cancer research, and structural biology.

David TremethickView profile

Professor

• Epigenetics
• Chromatin Dynamics
• Histone Variants
• +3 more

Professor David Tremethick leads the Chromatin and Transcriptional Regulation group at the John Curtin School of Medical Research, Australian National University. His lab investigates epigenetic mechanisms—particularly histone variants like H2A.Z—that regulate chromatin architecture, gene expression, and RNA processing during development and disease. Key research areas include 3D genome organization, epigenetic control of cell differentiation, and links between histone misincorporation and cancer. Recent work employs genome mapping, CRISPR editing, and biochemical approaches to dissect how histone variants influence chromatin compaction and splicing. Publications demonstrate a focus on H2A.Z's roles in development, cancer (e.g., Hodgkin lymphoma), and neurological function. Methodological innovation is evident in studies combining chromatin immunoprecipitation, isotope labeling, and advanced imaging. Major projects include investigations into histone variant functions in spermatogenesis and brain development using mouse models. No awards, students, or lab details are explicitly documented in provided texts.

• Cancer Metabolism
• Epigenetic Regulation
• Systems Biology
• +3 more

Dr. Ziwei Dai is an Assistant Professor at the Department of Biology, Southern University of Science and Technology, where she leads interdisciplinary research bridging computational and systems biology. She completed her PhD in Physical Chemistry at Peking University's Center for Quantitative Biology in 2016 and conducted postdoctoral training at Duke University's Department of Pharmacology and Cancer Biology (2016-2020). Research Focus: Cancer metabolism (glucose & amino acid dysregulation) Metabolic regulation of epigenetics/gene expression Biological network modeling Multi-omics data analysis Publication Trends: Her 15 most recent works (2018-2021) demonstrate expertise in metabolic network modeling, cancer epigenetics, and computational approaches to nutrient metabolism. Common subfields include flux analysis, chromatin biology, and tumor microenvironment characterization. Scientific Recognition: Robert J. Fitzgerald Scholar Award (2018) National Graduate Scholarship (2014) President Scholarship, Peking University (2014) Her research has achieved over 1,200 citations by 2021 and includes multiple cover articles in journals like Nature , Cell Metabolism , and Science Advances .

Katherine AlbaneseView profile

Assistant Professor

• Histone Posttranslational Modifications
• Protein Design
• Chemical Biology
• +3 more

Katherine Albanese is an Assistant Professor at Wake Forest University's Department of Chemistry. She leads the Albanese Lab, focusing on epigenetic pathways and developing novel therapeutic targets through protein design, chemical biology, and synthetic biology approaches. Her research integrates computational protein design, histone posttranslational modification (PTM) analysis, and synthetic cell systems to study gene regulation and epigenetic mechanisms. Education: BS in Chemistry (2016, Wake Forest University); PhD in Chemistry (2021, UNC Chapel Hill); Postdoctoral Researcher (2021-2024, University of Bristol, UK). Research Interests: Histone PTM dynamics, de novo protein design, synthetic cell models, oncogenic histone mutations, and combinatorial histone codes. Her lab employs a multi-disciplinary approach combining biochemistry, computational modeling, and synthetic biology to address fundamental questions in epigenetics. Key Research Areas: (1) New histone PTM discovery, (2) Aberrant histone mutations in cancer, (3) Synthetic cell platforms for epigenetic hypothesis testing. Recent work highlights engineered reader proteins, charge-agnostic binding mechanisms, and α-helical barrel design for therapeutic applications. Lab Website: albaneselab.com

Chuna Ram ChoudharyView profile

Professor

• Protein Post-Translational Modifications
• Cell Signaling Networks
• Proteomics
• +5 more

Dr. Chuna Ram Choudhary is a Professor and Group Leader at the Novo Nordisk Foundation Center for Protein Research (CPR) within the Faculty of Health and Medical Sciences at the University of Copenhagen , Denmark. His academic journey includes a PhD in Biochemistry (University of Münster, Germany, 2001–2006) and postdoctoral training at the Max Planck Institute for Biochemistry (2007–2009). He leads a research group focused on protein posttranslational modifications (PTMs) —particularly lysine acetylation and ubiquitylation —using quantitative mass spectrometry to map their roles in cell signaling networks and DNA repair . Research interests center on systems-wide analysis of PTMs, emphasizing their dynamic regulation of protein activity, stability, and localization in health and disease. His lab has pioneered methods for site-resolved acetylation stoichiometry and ubiquitylation dynamics , revealing connections between metabolism , transcription , and genome integrity . Collaborations span national and international institutions , including groups at CPR and beyond. Research output trends show a focus on ubiquitin and acetylation signaling , DNA repair mechanisms , and enhancer-promoter compatibility . His work has significant implications for cancer biology , cardiovascular diseases , and developmental processes . Scientific awards include: 2015: ERC Consolidator Grant 2014: Junior Researcher Prize (Danish Cancer Society) 2014: Hallas Møller Investigator Grant (NNF) 2013: EMBO Young Investigator 2012: Sapere Aude Grant (Danish Research Council) 2009: Artur Pappenheim Prize (German Society of Hematology and Oncology) Lab activities involve cutting-edge proteomics and mass spectrometry , with a strong emphasis on translational research and therapeutic target identification .

Peter SanderView profile

Professor

• Mycobacterium tuberculosis Research
• Antibiotic Resistance Mechanisms
• Vaccine Development
• +3 more

Peter Sander is a Full Professor at the University of Zurich , leading the Institute of Medical Microbiology 's research group focused on Mycobacterium tuberculosis and Mycobacterium abscessus . His research spans virulence mechanisms, lipoprotein biogenesis, vaccine innovation, and antibiotic resistance. Key research areas include Posttranslational modification of mycobacterial lipoproteins Drug susceptibility and resistance mechanisms RNA metabolism as antibiotic target Recent publications highlight advancements in 3',6'-disubstituted spectinomycins for efflux resistance, Fidaxomicin derivatives with enhanced activity, and Mycobacterium abscessus resistance gene characterization. Collaborations span institutions in Switzerland, France, Italy, and the U.S. Scientific honors include the Young Investigator Award from the German Society for Hygiene and Microbiology (2002). Supported by grants from the Swiss National Science Foundation, European Commission, and industry partners. Students mentored include Ph.D. candidates at the University of Zurich. His lab investigates lipoprotein synthesis pathways and host immunity interactions , with implications for tuberculosis and nontuberculous mycobacteria therapies.

Wenshe Ray LiuView profile

Professor

• Epigenetic Chromatin Regulation
• Histone Modifications
• Therapeutic Drug Development
• +3 more

Wenshe Ray Liu, PhD is a distinguished academic and researcher at Texas A&M University, holding the titles of Presidential Impact Fellow and Gradipore Endowed Chair in Chemistry . He serves as a Professor in the Department of Chemistry and Biochemistry and Biophysics, with dual appointments in both disciplines. His research spans epigenetic chromatin regulation and drug development targeting epigenetic proteins. Education : B.S. in Chemistry, Peking University (2000) PhD in Chemistry, University of California, Davis (2005) Postdoctoral Researcher at The Scripps Research Institute (2005–2007) Research Interests : Epigenetic regulation via histone posttranslational modifications (PTMs) Development of therapeutics targeting chromatin-modifying enzymes (SIRT1-3, HDACs, LSD1-2, ENL, BRD9) Chemical biology tools for chromatin assembly and analysis Phage display technologies for peptide library diversification His lab operates two core units: a biological unit focusing on chromatin structure-function studies and a chemical unit developing novel inhibitors and drug candidates. Grants & Awards : Presidential Impact Fellow (2018) ACS Chemical Biology Most Prolific Author (2017) NSF Career Award (2012) Molecular BioSystems Emerging Investigator (2010) Lab & Collaborations : Leverages cryo-EM, proteomics, and synthetic chemistry for structural and functional studies Active in SARS-CoV-2 main protease inhibitor discovery Develops genetic code expansion tools for site-specific protein modification

Feixia ChuView profile

Professor

• Proteomics
• Epigenetics
• Mass Spectrometry
• +4 more

Feixia Chu is a Professor in the Department of Molecular, Cellular, and Biomedical Sciences at the University of New Hampshire (UNH). Her research focuses on using mass spectrometry to study protein assemblies and posttranslational modifications, particularly in chromatin dynamics and structural biology. She develops innovative techniques like chemical cross-linking combined with mass spectrometry to elucidate protein interactions and conformational changes. Education: She holds a Ph.D. in Chemistry from the University of California, San Francisco (UCSF), an M.S. in Chemistry from the University of South Florida, and a B.S. in Chemistry from Wuhan University. Research Interests: Her lab investigates molecular recognition in protein complexes, structural dynamics of chromatin, and the role of posttranslational modifications in epigenetic regulation. Techniques include cross-linking mass spectrometry, quantitative proteomics, and biochemical purification strategies for histone variants. Publications: Over 40 peer-reviewed articles, including high-impact studies in Nature Communications , Cell , and Science Advances . Recent work addresses epichaperome networks in cellular adaptability and structural biology applications for SARS-CoV-2 proteomics. Teaching: Courses include Principles of Biochemistry, Protein Structure & Function, and Molecular & Cellular Biology research seminars. Labs/Teams: Her group integrates structural biology, proteomics, and biochemistry to tackle complex biological systems, with a focus on chromatin and protein complexes.

Yue ChenView profile

Associate Professor

• Proteomics
• Posttranslational Modifications
• Epigenetics
• +7 more

Dr. Yue Chen is an Associate Professor in the Department of Biochemistry, Molecular Biology and Biophysics at the University of Minnesota's College of Biological Sciences. His research focuses on discovering novel posttranslational modification (PTM) pathways involved in protein homeostasis, cellular signaling, and epigenetic regulation using mass spectrometry-based proteomics, chemical biology, and bioinformatics. Ph.D. from University of Texas at Arlington Postdoctoral training at University of Chicago Research Interests include: Quantitative chemical proteomics for lysine modification pathways Environmental impacts on PTM networks in cancer and metabolic diseases Development of stoichiometry analysis tools for ubiquitination and acetylation Epigenetic reprogramming via histone modifications Publications highlight his lab's innovations in crosslinking interactome analysis, constitutional isomer profiling, and hypoxia signaling. Awards include the NSF CAREER and NIH R35 MIRA grants, as well as HHMI Fellowships for inclusive excellence. His team includes graduate students and postdoctoral fellows working on cancer models, metabolic diseases, and environmental toxicology projects.

• Neuroscience
• Neurodegeneration
• Alzheimer's Disease
• +8 more

Gail V. Johnson, Ph.D. is a Professor at the University of Rochester School of Medicine and Dentistry , with appointments in the Department of Anesthesiology and Perioperative Medicine and as a joint member of the Department of Pharmacology and Physiology . Her research focuses on Alzheimer's disease and central nervous system injury , employing a multidisciplinary approach from molecular assays to animal models. Key areas include tau pathology , transglutaminase 2 (TG2) function , and mitochondrial quality control . Education: Ph.D. in Physiology, University of Delaware (1984) M.S. in Entomology, University of Massachusetts (1978) B.A. in Biology, Southampton College (1976) Her research interests center on: Understanding how tau protein dysregulation leads to neurofibrillary tangles in Alzheimer's disease. Investigating the cell-type-specific roles of TG2 in neuronal and astrocytic survival post-injury. Exploring mitochondrial dysfunction in neurodegeneration and its link to tau pathology. Developing therapeutic strategies targeting TG2 inhibitors for CNS injuries. Studying autophagy-lysosome pathways in protein clearance. Recent research trends from her publications highlight: Tau-aggregation and its impact on mitochondrial bioenergetics. TG2 as a double-edged sword —neuroprotective in neurons but detrimental in astrocytes. Epigenetic and pharmacological interventions to enhance tau clearance. Crosstalk between BAG3 , Nrf2 , and autophagy in neuroprotection. Scientific Awards and Grants: Ruth K. Broad Biomedical Research Foundation Awardee (1994-1996) Ciba Foundation Fellow Sponsor (1992) NIH First Award (1989-1994) Laboratory and Collaborations: Dr. Johnson's lab integrates in vitro and in vivo models to study molecular mechanisms, with recent work on Spinal Cord Injury and Alzheimer's disease models. Collaborations span biochemistry , neuropharmacology , and epigenetics to translate molecular insights into therapeutic strategies.

• Organic Chemistry
• Bioorganic Chemistry
• Medicinal Chemistry
• +5 more

Christian Adam Olsen is a Professor at the Department of Drug Design and Pharmacology , University of Copenhagen. With a foundation in chemical synthesis, his research group develops peptidomimetic secondary structures and chemical tools to investigate human lysine deacylase enzymes, HDAC inhibitors, and quorum sensing modulators.